03:25 PM EST - Lorus Therapeutics Inc. : announced that the United States Patent and Trademark Office has allowed a new patent for the Company's lead clinical stage cancer drug LOR-2040 in the treatment of Acute Myeloid Leukemia (AML). Lorus Therapeutics Inc.
shares T.LOR are trading up $0.08 at $0.79.
